Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT06469125
Other study ID # ResCORE-2024-12
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date June 15, 2024
Est. completion date December 30, 2024

Study information

Verified date June 2024
Source Necmettin Erbakan University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The Bladder Injury Classification System for Endoscopic Procedure (BICEP) is designed to provide a systematic framework for categorizing bladder injuries that occur during endoscopic procedures. By standardizing the classification of these injuries, BICEP promotes a more consistent approach to diagnosis, management, and prevention across different urologic interventions. This study aims to validate and implement the BICEP system during morcellation. This study will: Validate BICEP by using real-life clinical scenarios to ensure its applicability and effectiveness. Assess the incidence and types of bladder injuries during morcellation, using the BICEP categorization to standardize injury reporting and enhance treatment protocols.


Description:

Insufficient knowledge exists about bladder injuries during morcellation, as the existing literature primarily consists of isolated case reports. The Bladder Injury Classification System for Endoscopic Procedures (BICEP) aims to standardize the reporting and management of bladder injuries during endoscopic surgeries. This study proposes an external validation of the BICEP system through an international, multicenter, prospective observational study. The objectives of this study are fourfold: Validate the newly developed BICEP classification system with real-life clinical scenarios to ensure its applicability and effectiveness. Evaluate the incidence and types of bladder injuries during morcellation using the BICEP framework to standardize injury reporting and enhance treatment protocols. Assess the robustness of BICEP across different departments. Facilitate the adoption of BICEP as a global standard for classifying bladder injuries in endoscopic surgery. Through this study, the validity of BICEP will be confirmed and the bladder injuries occurring during morcellation after AEEP will be examined.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 250
Est. completion date December 30, 2024
Est. primary completion date December 15, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 40 Years and older
Eligibility Inclusion Criteria: - Patients aged =40 - ASA (American Society of Anesthesiologists) score =3 - Estimated weight on ultrasound (USG) =40 grams for prostate weight - Patients undergoing Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) surgery. Exclusion Criteria: - Patients with neurological disorders that may affect bladder function, such as cerebrovascular stroke or Parkinson's disease. - Patients with active urinary tract infection. - Patients diagnosed with bladder cancer within the last 2 years. - Patients with prostate cancer. - Patients who have undergone previous prostate surgery.

Study Design


Intervention

Procedure:
Endoscopic Prostate Interventions for Anatomic Enucleation
The intervention in this study involves performing anatomic endoscopic enucleation of the prostate (AEEP) using different energy sources. Following the enucleation, the resected prostate tissue will be morcellated within the bladder using various morcellators to remove the enlarged prostate tissue minimally invasively. The process will also involve evaluating and categorizing any resulting bladder injuries using the BICEP classification system.

Locations

Country Name City State
Turkey Istanbul Medipol University Hospital Istanbul
Turkey Necmettin Erbakan University Konya

Sponsors (18)

Lead Sponsor Collaborator
Necmettin Erbakan University Acibadem Ankara Hospital, Alexandria University, Asklepios Kliniken Hamburg GmbH, Danube University Krems, HM Sanchinarro University Hospital, Istanbul Medipol University Hospital, King's College Hospital NHS Trust, Martini-Klinik am UKE GmbH, Medical University of Graz, Menoufia University, Paracelsus Medical University, Saint Petersburg State University, Russia, Sheikh Khalifa Medical City, Spital Thurgau AG, Universitätsmedizin Mannheim, University General Hospital of Heraklion, University of Turin, Italy

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Breda A, Gallioli A, Diana P, Fontana M, Territo A, Gaya JM, Rodriguez-Faba O, Huguet J, Piana A, Verri P, Baboudjian M, Aumatell J, Algaba F, Palou J. The DEpth of Endoscopic Perforation scale to assess intraoperative perforations during transurethral re — View Citation

Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year exper — View Citation

Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR. Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol. 1998 Oct;12(5):457-9. doi: 10.1089/end.19 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Validation of BICEP Classification System Assess the applicability and effectiveness of the newly developed BICEP classification system using real-life clinical scenarios during anatomic endoscopic enucleation of the prostate.This validation will involve evaluating the system's accuracy and reliability in classifying bladder injuries occurring during morcellation. Up to 24 weeks
Secondary Incidence and Types of Bladder Injuries Evaluate the incidence and types of bladder injuries occurring during morcellation using the BICEP classification.This will involve standardizing injury reporting and enhancing treatment protocols based on the classification provided by the BICEP system. Up to 24 weeks
Secondary Robustness of BICEP Across Different Departments The existing BICEP classification in this study evaluates bladder injuries during surgery by considering every layer of the bladder, with the criterion for injury being a part of this classification.
To assess consistency, it is suitable to compare BICEP classifications across different surgeons or urology clinics in different hospitals. This comparison evaluates the similarity of classifications made by different surgeons or clinics on the same patient, thus helping to determine the overall consistency of the system.
As for reliability, it is appropriate to compare BICEP classifications within the same surgeon or urology clinic in the same hospitals. This assessment evaluates how close repeated classifications made by the same surgeon or clinic are to each other, aiding in determining the reliability of the system
Up to 24 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05443451 - BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY N/A
Recruiting NCT04288427 - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy N/A
Not yet recruiting NCT05017285 - Ejaculation Preservation After Laser Enucleation Prostate N/A
Completed NCT02778243 - Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level N/A
Completed NCT04212403 - Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB) N/A
Recruiting NCT05440981 - Implanted Nitinol Device (iTind) System in Chinese Males With Lower Urinary Tract Symptom Secondary to BPH N/A
Recruiting NCT05531240 - Transurethral Prostate Resection (TURP) vs. Prostate Artery Embolization (PAE) N/A
Recruiting NCT03176017 - Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP N/A
Completed NCT02244294 - FLOMAX® Versus Placebo, in Male Patients With Acute Urinary Retention Related to Benign Prostatic Hyperplasia (BPH) Phase 2
Recruiting NCT03966950 - Use of Melatonin for Preventing POCD in Transurethral Prostate Resection Under Spinal Anesthesia N/A
Recruiting NCT06116851 - Prostate Metabolism, Cancer Risk and Gut Microbiota
Completed NCT04781985 - Prostatic Resection Cavity Stone Post Transurethral Resection of the Prostate (TURP). A Rare Case Scenario N/A
Not yet recruiting NCT01876836 - Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications Phase 4
Completed NCT05941260 - Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
Completed NCT04580628 - Thuflep/SOLEP : Initial Experience and Results of Prostate Laser Enucleation With Thulium-fiber Laser (TFL)
Completed NCT04848181 - The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate Early Phase 1
Recruiting NCT06224218 - Prostate Single Port & Laser Enucleation Comparison Trial N/A
Completed NCT04781049 - Transperineal Laser Ablation vs Transurethral Resection for Benign Prostatic Obstruction: A Randomized Clinical Trial N/A
Completed NCT05059431 - The Effect of Human Prostate Tissue on Platelet Activation
Completed NCT05108662 - Inflammatory Markers: HOLEP Versus TURP N/A